Antimicrobial agents and MIC breakpoints (μg/mL) used in this study based on CLSI VET01S and ECOFFs criteria.

<p>Antimicrobial agents and MIC breakpoints (μg/mL) used in this study based on CLSI VET01S and ECOFFs criteria.</p

Odds ratios showing the likelihood of isolates being methicillin-resistant in <i>Staphylococcus pseudintermedius</i> isolates from dogs in Australia for different combinations of site of infection in the host and exposure of the host to prior antimicrobial treatment.

<p>Odds ratios showing the likelihood of isolates being methicillin-resistant in <i>Staphylococcus pseudintermedius</i> isolates from dogs in Australia for different combinations of site of infection in the host and exposure of the host to prior antimicrobial treatment.</p

Resistance profile per antimicrobial class found in clinical <i>Staphylococcus aureus</i> isolates from horses, dogs and cats in Australia (2013–2014)

<p>Resistance profile per antimicrobial class found in clinical <i>Staphylococcus aureus</i> isolates from horses, dogs and cats in Australia (2013–2014)</p

MIC distribution and frequency of resistance (%R) among clinical <i>Staphylococcus pseudintermedius</i> isolated from dogs (n = 616) and cats (n = 13) in Australia^a.

<p>MIC distribution and frequency of resistance (%R) among clinical <i>Staphylococcus pseudintermedius</i> isolated from dogs (n = 616) and cats (n = 13) in Australia<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0176379#t002fn001" target="_blank">^a</a>.</p

MIC distribution and frequency of resistance (%R) among clinical <i>Staphylococcus aureus</i> isolated from horses (n = 53), dogs (n = 47), and cats (n = 17) in Australia^b.

<p>MIC distribution and frequency of resistance (%R) among clinical <i>Staphylococcus aureus</i> isolated from horses (n = 53), dogs (n = 47), and cats (n = 17) in Australia<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0176379#t003fn002" target="_blank">^b</a>.</p

Univariate analysis of risk-factor variables from <i>Staphylococcus pseudintermedius</i> isolates from dogs in Australia (n = 555).

<p>Odds ratios define the risk of isolates being classified as methicillin-resistant strains.</p

Resistance profile per antimicrobial class found in clinical <i>Staphylococcus pseudintermedius</i> isolates in Australia (2013–2014)

<p>Resistance profile per antimicrobial class found in clinical <i>Staphylococcus pseudintermedius</i> isolates in Australia (2013–2014)</p

Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: Implications for workplace health and safety compliance

<div><p>Q fever vaccine uptake among veterinary nurses in Australia is low, suggesting veterinarians are not recommending the vaccination to veterinary personnel. This study aimed to determine the willingness of veterinarians to recommend Q fever vaccination to veterinary personnel and to identify factors influencing Q fever vaccine uptake by veterinary nurses in Australia. An online cross sectional survey targeted veterinarians and veterinary nurses in Australia in 2014. Responses were analysed using multivariable logistic regression. Factors significantly (p<0.05) associated with a willingness to recommend the vaccination, expressed by 35% (95% CI 31–38%) of veterinarians (n = 828), were (1) being very concerned for colleagues regarding <i>Coxiella burnetii</i> (OR 4.73), (2) disagreeing the vaccine is harmful (OR 3.80), (3) high Q fever knowledge (OR 2.27), (4) working within small animal practice (OR 1.67), (5) disagreeing the vaccine is expensive (OR 1.55), and (6) age, with veterinarians under 39 years most likely to recommend vaccination. Of the veterinary nursing cohort who reported a known Q fever vaccination status (n = 688), 29% (95% CI 26–33%) had sought vaccination. This was significantly (p<0.05) associated with (1) agreeing the vaccine is important (OR 8.34), (2) moderate/high Q fever knowledge (OR 5.51), (3) working in Queensland (OR 4.00), (4) working within livestock/mixed animal practice (OR 3.24), (5) disagreeing the vaccine is expensive (OR 1.86), (6) strong reliance on work culture for biosecurity information (OR 2.5), (7) perceiving personal exposure to <i>Coxiella burnetii</i> to be at least low/moderate (OR 2.14), and (8) both agreeing the vaccine is safe and working within a corporate practice structure (OR 4.28). The study identified the need for veterinarians to take greater responsibility for workplace health and safety promotion, and calls for better education of veterinary personnel to raise awareness of the potential for occupational exposure to <i>C</i>. <i>burnetii</i> and improve the perception of the Q fever vaccine as being important, safe and cost-effective.</p></div

Final multivariable model parameter estimates and odds ratios of factors significantly associated with Q fever vaccination status of veterinary nurses in Australia in 2014.

<p>Final multivariable model parameter estimates and odds ratios of factors significantly associated with Q fever vaccination status of veterinary nurses in Australia in 2014.</p

Final multivariable model parameter estimates and odds ratios of factors associated with a willingness to recommend Q fever vaccination among veterinarians surveyed in Australia in 2014.

<p>Final multivariable model parameter estimates and odds ratios of factors associated with a willingness to recommend Q fever vaccination among veterinarians surveyed in Australia in 2014.</p